Emerging management concepts for eosinophilic esophagitis in children

Journal of Gastroenterology and Hepatology (Australia)

Volumn 26, Issue 7, 2011, Pages 1106-1113

  Heine, Ralf G ^a,b,c   Nethercote, Mark ^a,b   Rosenbaum, Jeremy ^a   Allen, Katrina J ^a,b,c  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Aerosolized corticosteroids; Atopy; Elemental diet; Eosinophil; Esophagus; Food allergy

Indexed keywords

BUDESONIDE; FLUTICASONE; FOOD ALLERGEN; MEPOLIZUMAB; MONTELUKAST; PREDNISOLONE; PROTON PUMP INHIBITOR;

ARTICLE; ATOPY PATCH TESTING; DIAGNOSTIC TEST; DIET THERAPY; EOSINOPHILIC ESOPHAGITIS; ESOPHAGOSCOPY; EVIDENCE BASED MEDICINE; HUMAN; PRIORITY JOURNAL; SKIN PRICK TESTING;

EID: 79958781892     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2011.06757.x     Document Type: Article

References (74)

1. Furuta GT, Liacouras CA, Collins MH etal. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology 2007; 133: 1342-63.
2. Heine RG. Eosinophilic esophagitis in children with celiac disease: new diagnostic and therapeutic dilemmas. J. Gastroenterol. Hepatol. 2008; 23: 993-4.
3. Cherian S, Smith NM, Forbes DA. Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch. Dis. Child. 2006; 91: 1000-4.
4. Kapel RC, Miller JK, Torres C, Aksoy S, Lash R, Katzka DA. Eosinophilic esophagitis: a prevalent disease in the United States that affects all age groups. Gastroenterology 2008; 134:1316-21.
5. Noel RJ, Putnam PE, Rothenberg ME. Eosinophilic esophagitis. N. Engl. J. Med. 2004; 351: 940-1.
6. Prasad GA, Alexander JA, Schleck CD etal. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin. Gastroenterol. Hepatol. 2009; 7: 1055-61.
7. Veerappan GR, Perry JL, Duncan TJ etal. Prevalence of eosinophilic esophagitis in an adult population undergoing upper endoscopy: a prospective study. Clin. Gastroenterol. Hepatol. 2009; 7: 420-6. 426 e1-2.
8. Vanderheyden AD, Petras RE, DeYoung BR, Mitros FA. Emerging eosinophilic (allergic) esophagitis: increased incidence or increased recognition? Arch. Pathol. Lab. Med. 2007; 131: 777-9.
9. Ronkainen J, Talley NJ, Aro P etal. Prevalence of oesophageal eosinophils and eosinophilic oesophagitis in adults: the population-based Kalixanda study. Gut 2007; 56: 615-20.
10. Blanchard C, Mingler MK, Vicario M etal. IL-13 involvement in eosinophilic esophagitis: transcriptome analysis and reversibility with glucocorticoids. J. Allergy Clin. Immunol. 2007; 120: 1292-300.
11. Bullock JZ, Villanueva JM, Blanchard C etal. Interplay of adaptive th2 immunity with eotaxin-3/c-C chemokine receptor 3 in eosinophilic esophagitis. J. Pediatr. Gastroenterol. Nutr. 2007; 45: 22-31.
12. Kirsch R, Bokhary R, Marcon MA, Cutz E. Activated mucosal mast cells differentiate eosinophilic (allergic) esophagitis from gastroesophageal reflux disease. J. Pediatr. Gastroenterol. Nutr. 2007; 44: 20-6.
13. Lucendo AJ, Bellon T, Lucendo B. The role of mast cells in eosinophilic esophagitis. Pediatr. Allergy Immunol. 2009; 20: 512-18.
14. Hogan SP, Mishra A, Brandt EB, Foster PS, Rothenberg ME. A critical role for eotaxin in experimental oral antigen-induced eosinophilic gastrointestinal allergy. Proc. Natl. Acad. Sci. U.S.A. 2000; 97: 6681-6.
15. Liacouras CA, Spergel JM, Ruchelli E etal. Eosinophilic esophagitis: a 10-year experience in 381 children. Clin. Gastroenterol. Hepatol. 2005; 3: 1198-206.
16. Spergel JM, Andrews T, Brown-Whitehorn TF, Beausoleil JL, Liacouras CA. Treatment of eosinophilic esophagitis with specific food elimination diet directed by a combination of skin prick and patch tests. Ann. Allergy Asthma Immunol. 2005; 95: 336-43.
17. Assa'ad AH, Putnam PE, Collins MH etal. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J. Allergy Clin. Immunol. 2007; 119: 731-8.
18. Konikoff MR, Noel RJ, Blanchard C etal. A randomized, double-blind, placebo-controlled trial of fluticasone propionate for pediatric eosinophilic esophagitis. Gastroenterology 2006; 131: 1381-91.
19. Blanchard C, Wang N, Stringer KF etal. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J. Clin. Invest. 2006; 116: 536-47.
20. Bhattacharya B, Carlsten J, Sabo E etal. Increased expression of eotaxin-3 distinguishes between eosinophilic esophagitis and gastroesophageal reflux disease. Hum. Pathol. 2007; 38: 1744-53.
21. Blanchard C, Stucke EM, Burwinkel K etal. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J. Immunol. 2010; 184: 4033-41.
22. Rothenberg ME, Spergel JM, Sherrill JD etal. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat. Genet. 2010; 42: 289-91.
23. Patel SM, Falchuk KR. Three brothers with dysphagia caused by eosinophilic esophagitis. Gastrointest. Endosc. 2005; 61:165-7.
24. Collins MH, Blanchard C, Abonia JP etal. Clinical, pathologic, and molecular characterization of familial eosinophilic esophagitis compared with sporadic cases. Clin. Gastroenterol. Hepatol. 2008; 6: 621-9.
25. Chehade M, Sampson HA, Morotti RA, Magid MS. Esophageal subepithelial fibrosis in children with eosinophilic esophagitis. J. Pediatr. Gastroenterol. Nutr. 2007; 45: 319-28.
26. Aceves SS, Ackerman SJ. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol. Allergy Clin. North Am. 2009; 29: 197-211. xiii-xiv.
27. Lucendo AJ. Motor disturbances participate in the pathogenesis of eosinophilic oesophagitis, beyond the fibrous remodelling of the oesophagus. Aliment. Pharmacol. Ther. 2006; 24: 1264-7.
28. Miele E, Staiano A, Tozzi A, Auricchio R, Paparo F, Troncone R. Clinical response to amino acid-based formula in neurologically impaired children with refractory esophagitis. J. Pediatr. Gastroenterol. Nutr. 2002; 35: 314-19.
29. Böhmer CJ, Niezen-de Boer MC, Klinkenberg-Knol EC, Deville WL, Nadorp JH, Meuwissen SG. The prevalence of gastroesophageal reflux disease in institutionalized intellectually disabled individuals. Am. J. Gastroenterol. 1999; 94: 804-10.
30. Putnam PE. Eosinophilic esophagitis in children: clinical manifestations. Gastroenterol. Clin. North Am. 2008; 37: 369-81. vi.
31. Hill DJ, Heine RG, Cameron DJ etal. Role of food protein intolerance in infants with persistent distress attributed to reflux esophagitis. J. Pediatr. 2000; 136: 641-7.
32. Heine RG, Cameron DJ, Chow CW, Hill DJ, Catto-Smith AG. Esophagitis in distressed infants: poor diagnostic agreement between esophageal pH monitoring and histopathologic findings. J. Pediatr. 2002; 140: 14-19.
33. Allen KJ, Davidson GP, Day AS etal. Management of cow's milk protein allergy in infants and young children: an expert panel perspective. J. Paediatr. Child Health. 2009; 45: 481-6.
34. Elliott EJ, Thomas D, Markowitz JE. Non-surgical interventions for eosinophilic esophagitis. Cochrane Database Syst Rev. 2010; (3): CD004065.
35. DeBrosse CW, Collins MH, Buckmeier Butz BK etal. Identification, epidemiology, and chronicity of pediatric esophageal eosinophilia, 1982-1999. J. Allergy Clin. Immunol. 2010; 126: 112-19.
36. Spergel JM, Brown-Whitehorn TF, Beausoleil JL etal. 14years of eosinophilic esophagitis: clinical features and prognosis. J. Pediatr. Gastroenterol. Nutr. 2009; 48: 30-6.
37. Straumann A, Spichtin HP, Grize L, Bucher KA, Beglinger C, Simon HU. Natural history of primary eosinophilic esophagitis: a follow-up of 30 adult patients for up to 11.5years. Gastroenterology 2003; 125: 1660-9.
38. Straumann A. The natural history and complications of eosinophilic esophagitis. Gastrointest. Endosc. Clin. N. Am. 2008; 18: 99-118. ix.
39. Attwood SE. Mechanisms underlying dysphagia in eosinophilic oesophagitis. Gut 2009; 58: 1041-2.
40. Straumann A, Bussmann C, Zuber M, Vannini S, Simon HU, Schoepfer A. Eosinophilic esophagitis: analysis of food impaction and perforation in 251 adolescent and adult patients. Clin. Gastroenterol. Hepatol. 2008; 6: 598-600.
41. Cohen MS, Kaufman AB, Palazzo JP, Nevin D, Dimarino AJ, Jr, Cohen S. An audit of endoscopic complications in adult eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 2007; 5: 1149-53.
42. Wolfsen HC, Hemminger LL, Achem SR. Eosinophilic esophagitis and Barrett's esophagus with dysplasia. Clin. Gastroenterol. Hepatol. 2007; 5: A18.
43. Francalanci P, De Angelis P, Minnei F etal. Eosinophilic esophagitis and Barrett's esophagus: an occasional association or an overlap disease? Esophageal "double trouble" in two children. Digestion 2008; 77: 16-19.
44. Vasilopoulos S, Murphy P, Auerbach A etal. The small-caliber esophagus: an unappreciated cause of dysphagia for solids in patients with eosinophilic esophagitis. Gastrointest. Endosc. 2002; 55: 99-106.
45. Cantu P, Velio P, Prada A, Penagini R. Ringed oesophagus and idiopathic eosinophilic oesophagitis in adults: an association in two cases. Dig. Liver Dis. 2005; 37: 129-34.
46. Zimmerman SL, Levine MS, Rubesin SE etal. Idiopathic eosinophilic esophagitis in adults: the ringed esophagus. Radiology 2005; 236: 159-65.
47. Langdon DE. "Congenital" esophageal stenosis, corrugated ringed esophagus, and eosinophilic esophagitis. Am. J. Gastroenterol. 2000; 95: 2123-4.
48. Schoepfer AM, Gschossmann J, Scheurer U, Seibold F, Straumann A. Esophageal strictures in adult eosinophilic esophagitis: dilation is an effective and safe alternative after failure of topical corticosteroids. Endoscopy 2008; 40: 161-4.
49. Khan S, Orenstein SR, Di Lorenzo C etal. Eosinophilic esophagitis: strictures, impactions, dysphagia. Dig. Dis. Sci. 2003; 48: 22-9.
50. Jacobs JW Jr, Spechler SJ. A systematic review of the risk of perforation during esophageal dilation for patients with eosinophilic esophagitis. Dig. Dis. Sci. 2010; 55: 1512-15.
51. Sundaram S, Sunku B, Nelson SP etal. Adherent white plaques: an endoscopic finding in eosinophilic esophagitis. J. Pediatr. Gastroenterol. Nutr. 2004; 38: 208-12.
52. Spergel JM, Beausoleil JL, Mascarenhas M, Liacouras CA. The use of skin prick tests and patch tests to identify causative foods in eosinophilic esophagitis. J. Allergy Clin. Immunol. 2002; 109: 363-8.
53. Spergel JM, Brown-Whitehorn T, Beausoleil JL, Shuker M, Liacouras CA. Predictive values for skin prick test and atopy patch test for eosinophilic esophagitis. J. Allergy Clin. Immunol. 2007; 119: 509-11.
54. Kagalwalla AF, Sentongo TA, Ritz S etal. Effect of six-food elimination diet on clinical and histologic outcomes in eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 2006; 4: 1097-102.
55. Heine RG, Verstege A, Mehl A, Staden U, Rolinck-Werninghaus C, Niggemann B. Proposal for a standardized interpretation of the atopy patch test in children with atopic dermatitis and suspected food allergy. Pediatr. Allergy Immunol. 2006; 17: 213-17.
56. Helou EF, Simonson J, Arora AS. 3-yr-follow-up of topical corticosteroid treatment for eosinophilic esophagitis in adults. Am. J. Gastroenterol. 2008; 103: 2194-9.
57. Teitelbaum JE, Fox VL, Twarog FJ etal. Eosinophilic esophagitis in children: immunopathological analysis and response to fluticasone propionate. Gastroenterology 2002; 122: 1216-25.
58. Schaefer ET, Fitzgerald JF, Molleston JP etal. Comparison of oral prednisone and topical fluticasone in the treatment of eosinophilic esophagitis: a randomized trial in children. Clin. Gastroenterol. Hepatol. 2008; 6: 165-73.
59. Noel RJ, Putnam PE, Collins MH etal. Clinical and immunopathologic effects of swallowed fluticasone for eosinophilic esophagitis. Clin. Gastroenterol. Hepatol. 2004; 2: 568-75.
60. Aceves SS, Dohil R, Newbury RO, Bastian JF. Topical viscous budesonide suspension for treatment of eosinophilic esophagitis. J. Allergy Clin. Immunol. 2005; 116: 705-6.
61. Aceves SS, Newbury RO, Chen D etal. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65: 109-16.
62. Dohil R, Newbury R, Fox L, Bastian J, Aceves S. Oral viscous budesonide is effective in children with eosinophilic esophagitis in a randomized, placebo-controlled trial. Gastroenterology 2010; 139: 418-29.
63. Straumann A, Conus S, Degen L etal. Budesonide is effective in adolescent and adult patients with active eosinophilic esophagitis. Gastroenterology 2010; 139: 1526-37.e1.
64. Liacouras CA, Wenner WJ, Brown K, Ruchelli E. Primary eosinophilic esophagitis in children: successful treatment with oral corticosteroids. J. Pediatr. Gastroenterol. Nutr. 1998; 26: 380-5.
65. Kerlin P, Jones D, Remedios M, Campbell C. Prevalence of eosinophilic esophagitis in adults with food bolus obstruction of the esophagus. J. Clin. Gastroenterol. 2007; 41: 356-61.
66. Eisenbach C, Merle U, Schirmacher P etal. Perforation of the esophagus after dilation treatment for dysphagia in a patient with eosinophilic esophagitis. Endoscopy 2006; 38 (Suppl. 2): E43-4.
67. Dellon ES, Gibbs WB, Rubinas TC etal. Esophageal dilation in eosinophilic esophagitis: safety and predictors of clinical response and complications. Gastrointest. Endosc. 2010; 71: 706-12.
68. Kelly KJ, Lazenby AJ, Rowe PC, Yardley JH, Perman JA, Sampson HA. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology 1995; 109: 1503-12.
69. Markowitz JE, Spergel JM, Ruchelli E, Liacouras CA. Elemental diet is an effective treatment for eosinophilic esophagitis in children and adolescents. Am. J. Gastroenterol. 2003; 98: 777-82.
70. Spergel JM. Eosinophilic esophagitis in adults and children: evidence for a food allergy component in many patients. Curr. Opin. Allergy Clin. Immunol. 2007; 7: 274-8.
71. Spergel JM, Shuker M. Nutritional management of eosinophilic esophagitis. Gastrointest. Endosc. Clin. N. Am. 2008; 18: 179-94. xi.
72. Attwood SE, Lewis CJ, Bronder CS, Morris CD, Armstrong GR, Whittam J. Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut. 2003; 52: 181-5.
73. Stein ML, Collins MH, Villanueva JM etal. Anti-IL-5 (mepolizumab) therapy for eosinophilic esophagitis. J. Allergy Clin. Immunol. 2006; 118: 1312-19.
74. Straumann A, Conus S, Grzonka P etal. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial. Gut 2010; 59: 21-30.